Chronic Atrial Flutter: What Is the Risk of Thromboembolism?
In a review about atrial flutter, published in 1992, in the section concerning anticoagulant therapy, Olshansky et al.  concluded as follows: “A consensus has not yet been reached about the need for anticoagulation in patients with atrial flutter. It is not possible to make a rational judgement about the need for anticoagulation for patients with atrial flutter based on present data”.
KeywordsAtrial Fibrillation Sinus Rhythm Atrial Flutter Embolic Event Thromboembolic Risk
Unable to display preview. Download preview PDF.
- 1.Olshansky B, Wilber DJ, Hariman RJ (1992) Atrial flutter. Update on the mechanism and treatment. PACE 15:2308–2335Google Scholar
- 2.Pagadala P, Gummadi SS, Olshansky B (1994) Thromboembolic risk of chronic atrial flutter: is the risk underestimated? Circulation 90[Suppl]:I-398 (abstr)Google Scholar
- 6.Demsen CG (1999) Patients undergoing cardioversion of atrial flutter should be routinely anticoagulated. Am J Cardiol 83:140–141Google Scholar
- 14.Biblo LA, Chong Y, Kaufman ES, Lewis WR, Mackall JA, Rimm AA (1998) “Lone” atrial flutter, insights to embolic risk. PACE 21:515 (abstr)Google Scholar
- 15.Oreto G, Luzza F, Satullo G, Donato A (1997) I disordini del ritmo cardiaco. Centro Scientifico, Torino, pp 42–53Google Scholar